ClearPoint Neuro, Inc. CLPT
8.48 USD -0.01 (-0.12%)
At closeNov 13, 2026, 4:26 PM EST
8.48 0.00 0.00%
After hours · Nov 13, 4:26 PM ET
8.31 Day range 8.57
8.48 52-week range 19.43
- YTD
- -38.01%
- 1 year
- -45.29%
News
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ClearPoint Neuro, Inc. ("ClearPoint" or the "Company") (NASDAQ: CLPT). Such investors are…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ClearPoint Neuro, Inc. (“ClearPoint” or the “Company”) (NASDAQ: CLPT). Such investors are…
seekingalpha.com ClearPoint Neuro: Momentum Building Across The Business ClearPoint Neuro (CLPT) delivered solid Q3 results, with CAL service revenue ramping and capital equipment sales providing encouraging signs of future disposables growth. Multiple Phase III trials…
benzinga.com Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18 Stifel analyst Mathew Blackman maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $22 to $18.
benzinga.com ClearPoint Neuro Q3 2026 Earnings Call Transcript ClearPoint Neuro (NASDAQ:CLPT) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com ClearPoint Neuro Narrows FY2026 Sales Guidance from $48.000M-$52.000M to $48.000M-$50.000M vs $49.000M Est ClearPoint Neuro (NASDAQ:CLPT) narrows FY2026 sales outlook from $48.000 million-$52.000 million to $48.000 million-$50.000 million vs $49.000 million estimate.